Clinical significance of CEMIP in cancer has been highlighted by its upregulation in numerous human cancers, including breast, gastric, and colon cancers, and its negative correlation with patient survival [1, 3–5]. This evidence concerns the gene CEMIP and malignant colon neoplasm.